Dr. Linda Wilhelm and Dr. Meghan Elliott
Patient engagement in trainee supervision: Contextualizing findings from a kidney disease priority-setting partnership
Linda Wilhelm is the president of The Canadian Arthritis Patient Alliance, a national, grass-roots, volunteer, patient-driven organization. She is a member of the Drug Safety and Effectiveness Network’s steering committee, co-chair of the Chronic Pain and Evidence Alliance SPOR Network’s Steering Committee and a member of the Chronic Pain Network’s Patient Engagement Committee. Linda is a co-developer and co-facilitator of the web-based ‘Partners in Research’ course on patient oriented research for researchers, patients, health care providers and policy makers, and has co-facilitated several masterclasses on patient oriented research. She has been living with rheumatoid arthritis for over thirty five years and lives in Midland, New Brunswick.
Meghan Elliott is a nephrologist and Clinical Assistant Professor at the University of Calgary. She recently completed a Master’s of Science degree in Clinical Epidemiology at the University of Toronto under the supervision of Dr. Sharon Straus. Her graduate work focused on patient and stakeholder engagement in chronic kidney disease research and was supported by Alberta Innovates and KRESCENT post-doctoral fellowships. Her research interests include enhancing the engagement of persons living with chronic kidney disease in research and person-centered kidney care. She is involved in supporting knowledge translation within the SPOR-supported national kidney disease research network, Can-SOLVE CKD.
- To recognize ways in which stakeholder priorities may change over time
- To appreciate the perceived significance of research engagement
- To recognize novel opportunities for meaningful patient engagement in trainees' research